Halozyme Therapeutics, Inc. (HALO)
NASDAQ·Healthcare·Biotechnology
$83.22
-0.26%
Mkt Cap $9.66B
Analyst Ratings
Buy
4
Hold
1
Sell
0
Price Target (23 analysts)
$88.25
Range $75.00 – $95.00
Implied Upside
+6.1%
Consensus $88.25 vs current $83.22
NASDAQ·Healthcare·Biotechnology
$83.22
-0.26%
Mkt Cap $9.66B
Buy
4
Hold
1
Sell
0
Price Target (23 analysts)
$88.25
Range $75.00 – $95.00
+6.1%
Consensus $88.25 vs current $83.22